the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

China tightens border controls to keep mpox at bay

ANKARA: China has tightened its border control to prevent mpox virus from entering the country, state-run media reported on Saturday.

The country’s General Administration of Customs announced tighter surveillance measures for people and goods arriving from regions affected by mpox, Anadolu Agency quoting CGTN’s report said.

All travellers having symptoms such as fever, headaches, muscle pain, or rashes are required to report their condition upon entry.

The measures will remain in place for six months.

The Africa Centres for Disease Control and Prevention (Africa CDC) on Tuesday declared the mpox outbreak a “Public Health Emergency of Continental Security.”

The next day, the WHO declared the mpox situation a “public health emergency of international concern.”

Since the beginning of 2024, over a dozen African countries have reported the disease, with the Democratic Republic of Congo accounting for more than 90 per cent of reported cases.

A person infected with mpox develops symptoms within two to 19 days after exposure, according to health professionals.

According to the World Health Organisation (WHO), mpox causes rashes and flu-like symptoms.

Formerly known as monkeypox, mpox is a viral disease that can spread through close contact as well as through contaminated materials like sheets, clothing and needles, according to WHO. – Bernama, Anadolu Agency

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings